Innovex International vs Cactus
Add, change or remove companies; up to four.
KIRAβs take AI analyst
I put Innovex International and Cactus side by side, using each oneβs latest annual report. Here is what stands out:
- Cactus is the larger business, with $1.1B of revenue in fiscal 2025 against $978M for Innovex International.
- Innovex International grew revenue faster (48.0%, against β4.5%).
- Cactus kept more of each dollar of sales as operating profit (23.2% operating margin, against 13.6%).
Who comes out ahead
Of the 7 measures where higher (or lower) is clearly better, how many each company leads.
Innovex International
INVX
2/7
Revenue growthNet debt / EBITDA
Cactus
WHD
5/7
5-year growthGross marginOperating marginNet marginReturn on equity
Side by side
Best in the row
| Latest fiscal year | INVX FY25 | WHD FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.1B | β |
| Revenue | $978M | $1.1B |
| Free cash flow | β | β |
| Net income | $83.3M | $166M |
| Growth | ||
| Revenue growth | 48.0% | β4.5% |
| 5-year growth | 21.8% | 25.4% |
| Share count change | 37.0% | β |
| Profitability | ||
| Gross margin | 31.0% | 37.0% |
| Operating margin | 13.6% | 23.2% |
| Net margin | 8.5% | 15.4% |
| FCF margin | β | β |
| Return on capital | β | 17.1% |
| Return on equity | 8.3% | 14.5% |
| Balance sheet | ||
| Net debt | β$178M | β$107M |
| Net debt / EBITDA | β0.9x | β0.3x |
| Dividends and buybacks | $9.3M | $43.3M |
| Valuation & quality | ||
| P/E | 33.6x | β |
| Piotroski F-score | 5 | β |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.